C. Praml et al., Cancer Res., 58: 5014–5018, 1998

Re: Praml, C., Savelyeva, L., Perri, P., and Schwab, M. Cloning of the Human Aflatoxin B₁-Aldehyde Reductase Gene at 1p35–1p36.1 in a Region Frequently Altered in Human Tumor Cells. Cancer Res., 58: 5014–5018, November 15, 1998.

During the preparation of the above-referenced manuscript, we overlooked a recent publication that had reported the cDNA sequence of the human AFAR gene (Ireland, L.S., Harrison, D.J., Neal, G.E., and Hayes, J.D. Molecular cloning expression and catalytic activity of a human AKR7 member of the aldo-keto reductase superfamily: Evidence that the major 2-carboxybenzaldehyde reductase from human liver is a homologue of rat aflatoxin B₁-aldehyde reductase. Biochem. J., 332: 21–34, 1998).

Although we have been familiar with the long-standing and seminal contributions of the Hayes laboratory to the understanding of aflatoxin B₁-aldehyde reductase function, predominantly in the rat, and have referenced the corresponding work in our manuscript, this particular publication escaped our attention. We wish to apologize for this oversight, which occurred unintentionally. Both our work on tumor suppression and the work of the Hayes group on catalytic properties and expression are complementary and shed new light on the functions of these previously undiscovered members of the aldo-keto reductase superfamily.